CellaVision AB (LTS:0MR5) Net Change in Cash : kr15.3 Mil (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is CellaVision AB Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

CellaVision AB's Net Change in Cash for the three months ended in Mar. 2025 was kr32.9 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 was kr15.3 Mil.

CellaVision AB Net Change in Cash Historical Data

The historical data trend for CellaVision AB's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellaVision AB Net Change in Cash Chart

CellaVision AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

-0.05

28.03

-22.23

13.59

27.79

CellaVision AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Change in Cash	Get a 7-Day Free Trial															45.34	-44.72	15.40	11.77	32.89

CellaVision AB Net Change in Cash Calculation

CellaVision AB's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	198.438	+	-76.006	+	-95.089	+	0.443
	=	27.8

CellaVision AB's Net Change in Cash for the quarter that ended in Mar. 2025

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 61.426 + -21.192 + -3.485 + -3.862

= 32.9

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr15.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CellaVision AB Net Change in Cash Related Terms
Thank you for viewing the detailed overview of CellaVision AB's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

CellaVision AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (LTS:0MR5) » Definitions » Net Change in Cash

Comparable Companies

OSTO:BICO OSTO:MCAP OSTO:PAX OSTO:OSSD OSTO:BACTI B OSTO:SEDANA OSTO:CRAD B OSTO:SEZI OSTO:MNTC OSTO:PRO ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE

Traded in Other Exchanges

CEVI:Sweden CEVIs:UK C26:Germany C26:Germany

Address

Mobilvagen 12, Lund, SWE, 22362

Website

https://www.cellavision.com

CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers or software.

CellaVision AB Headlines

No Headlines